Alison Chrapczynski
Family · Chandler, AZNPI 1962123414
Payments from drug & device makers
Across 281 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$1K
- UCB, Inc.$872
- Pfizer$430
- Johnson & Johnson$329
- Radius Health, Inc.$327
- plus $1K from 18 others
What the payments were for
- Food & beverage$5,38498%
- Education$1062%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 60 | $1,082 |
| Amgen | 77 | $1,062 |
| UCB, Inc. | 25 | $872 |
| Pfizer | 23 | $430 |
| Johnson & Johnson | 14 | $329 |
| Radius Health, Inc. | 15 | $327 |
| Novartis | 16 | $290 |
| Mallinckrodt Hospital Products Inc. | 7 | $217 |
| E.r. Squibb & Sons, L.L.C. | 6 | $114 |
| Actelion Pharmaceuticals US, Inc. | 4 | $102 |
| ANI Pharmaceuticals, Inc. | 5 | $94 |
| Almatica Pharma LLC | 4 | $79 |
| Boehringer Ingelheim | 4 | $70 |
| Fresenius Kabi USA, LLC | 2 | $58 |
| Lilly USA, LLC | 3 | $55 |
| Organon | 3 | $43 |
| Scilex Pharmaceuticals Inc. | 2 | $43 |
| AstraZeneca(2 entities) | 2 | $41 |
| Aurinia Pharma U.S., Inc. | 2 | $40 |
| GSK | 2 | $38 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $34 |
| Genentech USA, Inc. | 2 | $33 |
| Sanofi | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $18 |
How this compares
$5,491 in reported general payments places this provider in the 90th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 13 | $97,909 |
| Hydroxychloroquine Sulfate | 413 | $18,914 |
| MethotrexateMethotrexate Sodium | 292 | $8,386 |
| Leflunomide | 63 | $4,046 |
| Mycophenolate Mofetil | 39 | $3,122 |
| Sulfasalazine | 60 | $2,692 |
| Cevimeline Hcl | 24 | $2,498 |
| Sulfasalazine DrSulfasalazine | 38 | $1,939 |
| Folic Acid | 117 | $1,468 |
| Azathioprine | 17 | $1,206 |
| Celecoxib | 12 | $1,198 |
| Prednisone | 111 | $931 |
| Allopurinol | 50 | $820 |
| Colchicine | 19 | $641 |
| Methotrexate SodiumMethotrexate Sodium/Pf | 29 | $533 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Scilex Pharmaceuticals Inc.Colchicine | $43 | $64119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,119 family providers in Arizona.
Other family in Chandler
- Mia ChorneyChandler$79K
- Simon ParkinsonChandler$40K
- Anjanette KibbyChandler$21K
- Courtney BrzyckiChandler$14K
- Sharon MagalonaMesa$449K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Rebecca McCollaumMesa$149K
- Susan SarabiaSun City West$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.